Dr. George is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
N Medical Dr
Salt Lake City, UT 84132Phone+1 505-272-3203
Summary
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematopathology, 1998 - 1999
- University of California (San Francisco)Residency, Pathology-Anatomic and Clinical, 1995 - 1998
- University of California San Francisco School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1997 - 2026
- UT State Medical License 2017 - 2026
- NM State Medical License 2012 - 2019
- FL State Medical License 2013 - 2018
- AZ State Medical License 2014 - 2016
- LA State Medical License 2015 - 2016
- NV State Medical License 2011 - 2015
- American Board of Pathology Anatomic Pathology & Clinical Pathology
- American Board of Pathology Hematology
Awards, Honors, & Recognition
- Lifetime Achievement Award College of American Pathologists, 2014
Publications & Presentations
PubMed
- 11 citationsRosai-Dorfman Disease of the Breast With Variable IgG4+ Plasma Cells: A Diagnostic Mimicker of Other Malignant and Reactive Entities.Jenny C. Hoffmann, Chieh Yu Lin, Siddhartha Bhattacharyya, Olga K. Weinberg, Karen M. Chisholm
The American Journal of Surgical Pathology. 2019-12-01 - 136 citationsThe new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatmentJason Gotlib, Julia E. Maxson, Tracy I. George, Jeffrey W. Tyner
Blood. 2013-09-05 - 38 citationsStandards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)Peter Valent, Attilio Orazi, Guntram Büsche, Annette Schmitt-Gräff, Tracy I. George
Oncotarget. 2010-11-16
Lectures
- Diagnostic Testing Patterns and Concordance with World Health Organization (WHO) Criteria for Patients (Pts) with Newly Diagnosed (ND) Myelodysplastic Syndromes (MDS) ...61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Comprehensive Cytokine Profiling of Patients with Advanced Systemic Mastocytosis Treated with Midostaurin2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Other
- An Analysis of Blastic Plasmacytoid Dendritic Cell Neoplasm with Translocations Involving the MYC Locus Identifies T(6;8)(p21;q24) as a Recurrent Cytogenetic AbnormalityTracy George, MD, Histopathology
https://www.doximity.com/articles/1a71c584-7f04-41fe-b0e6-7edde6117d59
UpToDate, Wolters Kluwer Health - 2012-07-24
Press Mentions
- 2022 Healthcare HeroesOctober 3rd, 2022
- Higher Stakes in Systemic MastocytosisJune 18th, 2021
- ARUP Announces Retirement of CEO Sherrie L. Perkins, Appointment of President Andy Theurer to Replace Her as CEOApril 13th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: